Tenders of A O U Ospedali Riuniti Foggia

Negotiated Procedure, Pursuant to Article 76, Paragraph 4, Letter B) of Legislative Decree 36/2023, for the Implementation and Installation of N. 3 (three) Secondary Supports for Pentax Endoscopic Columns, Used in the Al D'avanzo Pneumology Departments, Endoscopic Plate, Thoracic Surgery of the Foggia Polyclinic - Request for Expense Estimate

Telematic Negotiated Procedure Art. 76, Paragraph 2 Letter B) of Legislative Decree 36/2023 for the Annual Supply under the Administration Regime of the Medicinal Specialty with the Active Ingredient “delutegravir Sodium/abacavir Sulphate/lamivudine” Triumeq Cpr Riv 50 Mg + 600 Mg + 300 Mg Bottle – Atc J05ar13 – Aic 043618014

Award Pursuant to Art. 50, Paragraph 1, Letter B) of Legislative Decree 36/2023 for the Annual Supply under the Administration Regime of the Following Active Ingredient “Sodium Chloride, Potassium Chloride, Calcium Chloride, Magnesium Chloride, Sodium Acetate, Sodium Citrate” Electrolytic Rehydrating Iii Fl 250 Ml – Atc B05bb01.

Negotiated Procedure Pursuant to Art. 76, Paragraph 2, Letter B) of Legislative Decree 36/2023 for the Annual Supply under the Administration Regime of the Medicinal Specialty Referred to in the Following Active Ingredient “Water for Injectable Preparations” 500 ml Bag, Atc V07ab – Aic 030906438.

Telematic Negotiated Procedure Art. 76, Paragraph 2 Letter B) of Legislative Decree 36/2023 for the Annual Supply under the Administration Regime of the Medicinal Specialty with the Active Ingredient “epcoritamab” Tepkinly Injectable Solution Various Dosages – Atc L01fx27

Open Procedure in Telematic Mode, Pursuant to Art. 71 of Legislative Decree No. 36/2023 for the awarding of the three-year supply of dietary products required by the facilities of the Foggia Polyclinic – 23 Lots – to be awarded with the lowest price criterion pursuant to art. 108, Co. 1 and 3 of Legislative Decree No. 36/2023. Various Cig.

Award Pursuant to Art. 50, Paragraph 1, Letter B) of Legislative Decree 36/2023 and subsequent amendments for the Annual Supply under the Administration Regime of the Following Active Ingredient “amikacin Sulphate” 500 Mg 2 Ml – Atc J01gb06.